March 8 Noontime forum to Cover Harm Reduction Approaches to Reducing Drug Use

March 3, 2022

The MMA’s next noon-time forum, which will discuss harm reduction approaches to reducing drug use, takes place March 8 from noon to 1 p.m.   

The forum will include the following experts: 

  • Heather Bell, MD, FASAM, FAAFP, Addiction Services and Primary Care, CentraCare 

  • Ryan Kelly, MD, MS, Internal Medicine, Pediatrics, Harm Reduction Addiction, Community-University Health Care Center at the University of Minnesota, SouthSide Harm Reduction 

  • Sheila P. Vakharia PhD LMSW, Deputy Director, Department of Research and Academic Engagement, Drug Policy Alliance 

Learning objectives for the forum include:  

  • Explore harm reduction approaches to reducing drug use.  

  • Describe the harm reduction approaches currently being used in Minnesota.  

  • Identify policies needed to lessen the personal and public health impacts of behavior associated with alcohol and other substance use. 

To register, click here.  

The forum is free to members, $15 for non-members. This forum is being sponsored by AstraZeneca and COPIC. 

Latest News

State Supports Universal Hepatitis B Vaccine Birth Dose

December 11, 2025

On December 5, the Advisory Committee on Immunization Practices (ACIP) voted to eliminate the universal hepatitis B vaccine recommendation for infants.  

MMA Signs on to Bill to Ease Senior Access to Care

December 11, 2025

The MMA, along with other state medical associations and 75 specialty societies, signed on to a letter to Congressional leaders urging passage of the “Improving Seniors’ Timely Access to Care Act of 2025.” 

Physicians Tackle Payment Reform, Public Health, and More at AMA Interim Meeting

December 11, 2025

Physicians from Minnesota and across the country gathered November 14-18 for the AMA 2025 Interim Meeting in National Harbor, Maryland, to address payment reform, public health challenges, rural healthcare, and the escalating administrative and financial pressures on medical practice.